Authors:
CARACENI A
MARTINI C
SPATTI G
THOMAS A
ONOFRJ M
Citation: A. Caraceni et al., RECOVERING OPTIC NEURITIS DURING SYSTEMIC CISPLATIN AND CARBOPLATIN CHEMOTHERAPY, Acta neurologica Scandinavica, 96(4), 1997, pp. 260-261
Authors:
DEBENEDETTI VMG
RADICE P
MONDINI P
SPATTI G
CONTI A
ILLENI MT
CALIGO MA
CIPOLLINI G
BEVILAQUA G
PILOTTI S
PIEROTTI MA
Citation: Vmg. Debenedetti et al., SCREENING FOR MUTATIONS IN EXON-11 OF THE BRCA1 GENE IN 70 ITALIAN BREAST AND OVARIAN-CANCER PATIENTS BY PROTEIN TRUNCATION TEST, Oncogene, 13(6), 1996, pp. 1353-1357
Authors:
RIGHETTI SC
DELLATORRE G
PILOTTI S
MENARD S
OTTONE F
COLNAGHI MI
PIEROTTI MA
LAVARINO C
CORNAROTTI M
ORIANA S
BOHM S
BRESCIANI GL
SPATTI G
ZUNINO F
Citation: Sc. Righetti et al., A COMPARATIVE-STUDY OF P53 GENE-MUTATIONS, PROTEIN ACCUMULATION, AND RESPONSE TO CISPLATIN-BASED CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA, Cancer research, 56(4), 1996, pp. 689-693
Authors:
DILEO A
BAJETTA E
BIGANZOLI L
BOHM S
MARIANI L
MENARD S
PILOTTI S
FABBIANI M
GEBBIA V
ORIANA S
OTTONE F
RIBOLDI G
SAVA C
SPATTI G
ZUNINO F
DIRE F
Citation: A. Dileo et al., AN ITMO GROUP-STUDY ON 2ND-LINE TREATMENT IN ADVANCED EPITHELIAL OVARIAN-CANCER - AN ATTEMPT TO IDENTIFY CLINICAL AND BIOLOGICAL FACTORS DETERMINING PROGNOSIS, European journal of cancer, 31A(13-14), 1995, pp. 2248-2254
Authors:
SHATTUCKEIDENS D
MCCLURE M
SIMARD J
LABRIE F
NAROD S
COUCH F
HOSKINS K
WEBER B
CASTILLA L
ERDOS M
BRODY L
FRIEDMAN L
OSTERMEYER E
SZABO C
KING MC
JHANWAR S
OFFIT K
NORTON L
GILEWSKI T
LUBIN M
OSBORNE M
BLACK D
BOYD M
STEEL M
INGLES S
HAILE R
LINDBLOM A
OLSSON H
BORG A
BISHOP DT
SOLOMON E
RADICE P
SPATTI G
GAYTHER S
PONDER B
WARREN W
STRATTON M
LIU QY
FUJIMURA F
LEWIS C
SKOLNICK MH
GOLDGAR DE
Citation: D. Shattuckeidens et al., A COLLABORATIVE SURVEY OF 80 MUTATIONS IN THE BRCA1 BREAST-CANCER ANDOVARIAN-CANCER SUSCEPTIBILITY GENE - IMPLICATIONS FOR PRESYMPTOMATIC TESTING AND SCREENING, JAMA, the journal of the American Medical Association, 273(7), 1995, pp. 535-541
Authors:
DILEO A
BAJETTA E
BIGANZOLI L
BOHM S
LUPI G
ORIANA S
RIBOLDI G
SPATTI G
ZUNINO F
DIRE F
Citation: A. Dileo et al., MITOXANTRONE AND IFOSFAMIDE AS 2ND-LINE THERAPY OF EPITHELIAL OVARIAN-CANCER - A PILOT-STUDY BY THE ITMO GROUP, European journal of cancer, 30A(14), 1994, pp. 2188-2188
Authors:
DILEO A
BIGANZOLI L
BOHM S
LUPI G
ORIANA S
RIBOLDI G
SPATTI G
VICARIO G
DIRE F
BAJETTA E
Citation: A. Dileo et al., AN INTENSIVE TREATMENT WITH MITOXANTRONE AND IFOSFAMIDE IN 2ND-LINE THERAPY OF EPITHELIAL OVARIAN-CANCER, Tumori, 80(6), 1994, pp. 443-447
Authors:
DILEO A
BAJETTA E
NOLE F
BIGANZOLI L
FERRARI L
ORIANA S
RIBOLDI G
BOHM S
SPATTI G
RASPAGLIESI F
DIRE E
FONTANELLI R
TAIANA A
ZANON P
ZUNINO F
DIRE F
Citation: A. Dileo et al., THE INTRAMUSCULAR ADMINISTRATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR AS AN ADJUNCT TO CHEMOTHERAPY IN PRETREATED OVARIAN-CANCER PATIENTS - AN ITALIAN-TRIALS-IN-MEDICAL-ONCOLOGY (ITMO) GROUP PILOT-STUDY, British Journal of Cancer, 69(5), 1994, pp. 961-966